Press Releases

News Brief

Samsung Biologics showcases CDO capabilities at BPI 2023

Samsung Biologics showcases CDO capabilities at BPI 2023

Samsung Biologics showcased its latest capacity expansion and CDO capabilities at BioProcess International 2023 held in Boston between September 18-21.
 

The company shared the latest developments regarding Bio Campus II and promoted its CDO services, including proprietary platforms and new customized CMC solutions for optimized drug development.
 

Samsung Biologics also participated in poster sessions as well as a speaking session where Lee, Director of Cell Line Development, shared her insights on how utilizing the company's S-CHOice® CLD platform can maximize protein efficiency.
 

To learn more about Samsung Biologics' CDO services, visit the CDO page or download the  brochure for more information.

Samsung Biologics showcases CDO capabilities at BPI 2023

Samsung Biologics showcased its latest capacity expansion and CDO capabilities at BioProcess International 2023 held in Boston between September 18-21.
 

The company shared the latest developments regarding Bio Campus II and promoted its CDO services, including proprietary platforms and new customized CMC solutions for optimized drug development.
 

Samsung Biologics also participated in poster sessions as well as a speaking session where Lee, Director of Cell Line Development, shared her insights on how utilizing the company's S-CHOice® CLD platform can maximize protein efficiency.
 

To learn more about Samsung Biologics' CDO services, visit the  CDO page  or download the  brochure  for more information.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION